ICD-10 Coding for Bicytopenia(D61.1, D61.818)
Complete ICD-10-CM coding and documentation guide for Bicytopenia. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Bicytopenia
D61.1-D61.9Primary Range
Aplastic anemia and other bone marrow failure syndromes
This range includes codes for aplastic anemia and other bone marrow failure syndromes, which can be associated with bicytopenia.
Other specified and unspecified anemias
These codes may be used when bicytopenia is due to anemia of unspecified or other specified causes.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D61.1 | Drug-induced aplastic anemia with bicytopenia | Use when bicytopenia is due to drug-induced aplastic anemia. |
|
| D61.818 | Other pancytopenia | Use when bicytopenia is idiopathic or non-drug-induced. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for bicytopenia
Essential facts and insights about Bicytopenia
Primary ICD-10-CM Codes for bicytopenia
Decision Criteria
clinical Criteria
- Documented drug-induced cause with two cytopenias.
Applicable To
- Bicytopenia due to drug treatment
Excludes
- Pancytopenia (D61.81)
Clinical Validation Requirements
- ANC <1,800
- Hgb <12g/dL (F)/<13g/dL (M)
- Plt <150,000
Code-Specific Risks
- Ensure drug causation is documented.
Coding Notes
- Ensure documentation specifies drug causation and affected cell lines.
D61.818 - Other pancytopenia
Use when bicytopenia is idiopathic or non-drug-induced.
Applicable To
- Bicytopenia not otherwise specified
Excludes
- Drug-induced bicytopenia (D61.1)
Clinical Validation Requirements
- Two cytopenias with bone marrow biopsy showing hypoplasia
Coding Notes
Document the specific cell lines affected and any underlying conditions.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Bicytopenia to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D61.1.
Impact
Clinical: Leads to mismanagement of underlying cause., Regulatory: Increases risk of non-compliance with coding standards., Financial: Potential for reduced reimbursement.
Mitigation Strategy
Always document drug name and dosage., Link cytopenia onset to drug administration.
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Increases risk of audit due to unspecified coding., Data Quality: Reduces accuracy of clinical data.
Mitigation Strategy
Use specific codes like D61.1 or D61.818 based on etiology.
Impact
Using unspecified codes increases audit risk.
Mitigation Strategy
Document specific cell lines and causes.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Bicytopenia, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Bicytopenia
Use these documentation templates to ensure complete and accurate documentation for Bicytopenia. These templates include all required elements for proper coding and billing.
Bicytopenia due to chemotherapy
Specialty: HematologyRequired Elements
- Specific cell lines affected
- Drug name and dosage
- Bone marrow biopsy results
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Bicytopenia? Ask your questions below.